Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3081 Target Snapshot

Aldo-keto reductase family 1 member B1 · SINGLE PROTEIN · Bos taurus

747Compounds
136Assays
4Approved Drugs
435.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P16116. Use UniProt P16116 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P16116 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Aldo-keto reductase family 1 member B1 as ChEMBL target CHEMBL3081, mapped to UniProt P16116. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Aldo-keto reductase family 1 member B1
SINGLE PROTEIN · Bos taurus
As of 2026-09-13
ChEMBL target ID
CHEMBL3081
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P16116
Aldo-keto reductase family 1 member B1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Aldo-keto reductase family 1 member B1 is the right protein anchor across sources, using UniProt P16116 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAldo-keto reductase family 1 member B1
UniProt AccessionP16116
Component TypeProtein
Sequence Length315 aa

Aldo-keto reductase family 1 member B1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Aldo-keto reductase family 1 member B1, mapped to UniProt P16116. Sequence length is 315 aa.

Mapped IDP16116
Review nameAldo-keto reductase family 1 member B1
OrganismBos taurus
Clinical Profile

Clinical Phase Distribution

4
Approved
2
Phase III
5
Phase II
Assay Mix

Activity Type Distribution

IC50431.0
KI4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL7679 8.15 IC50 7.0 Clinical
CHEMBL292963 8.05 IC50 9.0 Preclinical
CHEMBL142239 8.05 IC50 9.0 Preclinical
CHEMBL64091 8.01 IC50 9.7 Preclinical
CHEMBL358284 7.96 IC50 11.0 Preclinical
CHEMBL273910 7.85 IC50 14.0 Clinical
CHEMBL292486 7.82 IC50 15.0 Preclinical
CHEMBL358825 7.82 IC50 15.0 Preclinical
CHEMBL62478 7.77 IC50 17.0 Preclinical
CHEMBL64543 7.75 IC50 18.0 Preclinical
Distribution

pChEMBL Value Distribution

79
5.0
47
5.5
53
6.0
34
6.5
24
7.0
25
7.5
4
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

EPALRESTAT
CHEMBL56337
Approved 1992
TOLRESTAT
CHEMBL436
Approved 1989
Assay Landscape

Assay Landscape

136
Total Assays
324
Tested Compounds
2
Assay Types
Binding — 134 assays, 324 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 125 317 5.5
tissue-based format 5 3 4.7
organism-based format 3 0
assay format 1 4 5.2
Functional — 2 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 15 7.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine